Showing results (271-280 of 347) with videos related to
Sort By:
Pageof 35
Toxins|November 21, 2018
Delayed LY333013 (Oral) and LY315920 (Intravenous) Reverse Severe Neurotoxicity and Rescue Juvenile Pigs from Lethal Doses of <i>Micrurus fulvius</i> (Eastern Coral Snake) VenomMatthew R Lewin, Lyndi L Gilliam, John Gilliam, et al.Diagnostic Microbiology and Infectious Disease|June 29, 2019
T2 Candida versus beta-D-glucan to facilitate antifungal discontinuation in the intensive care unitChristian M Gill, Rachel M Kenney, Laura Hencken, et al.Trials|January 10, 2016
Comparative effectiveness of antihypertensive treatment for older children with primary hypertension: study protocol for a series of n-of-1 randomized trialsJoyce P Samuel, Joshua A Samuels, Lauren E Brooks, et al.Toxicon : Official Journal of the International Society on Toxinology|November 15, 2024
In vitro anticoagulant effects of Bungarus venoms on human plasma which are effectively neutralized by the PLA<sub>2</sub>-inhibitor varespladibAbhinandan Chowdhury, Bryan G Fry, Stephen P Samuel, et al.American Journal of Hypertension|July 1, 1988
Isradipine (PN 200-110) versus hydrochlorothiazide in mild to moderate hypertension. A multicenter studyP K Mohanty, L M Gonasun, R P Goodman, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 31, 2019
Improving care for critically ill patients with community-acquired pneumoniaMonica L Bianchini, Nicholas J Mercuro, Rachel M Kenney, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1991
Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia virusesY M Chen, X Q Zhang, C E Dahl, et al.Toxins|November 24, 2022
Varespladib in the Treatment of Snakebite Envenoming: Development History and Preclinical Evidence Supporting Advancement to Clinical Trials in Patients Bitten by Venomous SnakesMatthew R Lewin, Rebecca W Carter, Isabel A Matteo, et al.The Journal of Arthroplasty|January 1, 1987
Infection rate in total hip arthroplasty as a function of air cleanliness and antibiotic prophylaxis. 10-year experience with 2,384 cementless Lord madreporic prosthesesJ H Marotte, G A Lord, J P Blanchard, et al.Dalton Transactions (Cambridge, England : 2003)|June 18, 2013
Lewis-base stabilized diiodine adducts with N-heterocyclic chalcogenamidesMykyta Tretiakov, Yuriy G Shermolovich, Amit Pratap Singh, et al.Pageof 35